About this trial
LifeBioMEMORY (LBM) is a reminiscence therapy (RT) mobile application that captures older adults' life stories in their own voices to promote social engagement and psychosocial well-being. This study will develop and evaluate an enhanced multilingual LBM app for community-dwelling, diverse older adults with mild cognitive impairment (MCI) or at risk of MCI and their informal caregivers, including Hispanic/Latino, Asian American (as one of subgroups, Korean), Black or African American, and non-Hispanic White populations. The app provides culturally tailored life story prompts with audio and visual cues to encourage reminiscence and storytelling. The intervention aims to improve quality of life, reduce depressive symptoms and loneliness, and strengthen caregiver-care recipient relationships, with the potential to provide an accessible, non-pharmacological approach to supporting cognitive and emotional well-being.
Eligibility criteria
Qualifiers
None
Disqualifiers
Self-identified as Hispanic/Latino, Korean, Black/African American, and Non-Hispanic White
Speak and read Spanish, Korean, or English
Aged 60 years and older, with Montreal Cognitive Assessment (MoCA) test scores ranging 18-30 (with MCI: 18-25, or at risk for MCI: 26-30)
Have a local or in-home informal caregiver who can participate who is age 18 or older
Trial design
Treatments tested in this trial
- LifeBio Memory (LBM) digital reminiscence intervention
Treatment groups
Locations
Sponsors and collaborators
George Mason University
Lead sponsor
National Institute on Aging (NIA)
Collaborator